. 2022 Jan 27;9:799494. doi: 10.3389/fmed.2022.799494
Copyright © 2022 Karlsdottir, Gunnarsdottir, Grondal, Love, Stefansdottir, Davidsdottir, Thorleifsdottir and Gudbjornsson.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
Figure 1.
Proportion of 198 patients who received instructions on Humira® and Imraldi® injection devices.